
"Uncovering Rare Cases of Transmissible Alzheimer's in Medical Treatment Recipients"
Scientists have documented the first cases of transmitted Alzheimer's disease, linked to a discontinued medical procedure involving the use of growth hormone extracted from human cadavers. The hormone transplant inadvertently transferred beta-amyloid protein into recipients' brains, leading to the development of Alzheimer's in some patients decades later. While these cases are rare and not a public health concern, they provide insight into the potential transmission of Alzheimer's and raise questions about the disease's underlying mechanisms.

